Literature DB >> 1610217

Immunohistochemical studies on NAP-1/IL-8 in contact eczema and atopic dermatitis.

M Sticherling1, E Bornscheuer, J M Schröder, E Christophers.   

Abstract

The neutrophil activating peptide NAP-1/IL-8 has in the past been shown to be secreted by diverse cell-types involved in inflammatory processes. Furthermore, potent biological effects on both neutrophilic granulocytes and lymphocytes enforce its role in inflammation. Recently, immunohistochemical studies using monoclonal anti-NAP-1/IL-8 antibodies have been performed on dermal inflammatory conditions like psoriasis vulgaris. These have demonstrated epidermal IL-8 immunoreactivity in a pattern inversely related to the degree of inflammatory infiltration. Based on these results, in the present study biopsies from patients with contact eczema as well as atopic dermatitis were examined. The same patterns of immunoreactivity were found with either homogeneous epidermal staining, focally negative staining or overall decreased or even absent staining. As in psoriasis, these patterns were related to the degree of inflammatory infiltration. These results prove NAP-1/IL-8 to be involved not only in psoriasis vulgaris, but more likely to be a marker of different inflammatory processes. Future work will have to examine the kinetics as well as stimuli causing these effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610217     DOI: 10.1007/bf00373374

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  13 in total

1.  Production and characterization of monoclonal antibodies against the novel neutrophil activating peptide NAP/IL-8.

Authors:  M Sticherling; J M Schröder; E Christophers
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

2.  Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors.

Authors:  J N Barker; V Sarma; R S Mitra; V M Dixit; B J Nickoloff
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

Review 3.  Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF.

Authors:  K Matsushima; J J Oppenheim
Journal:  Cytokine       Date:  1989-11       Impact factor: 3.861

Review 4.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

5.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor.

Authors:  C G Larsen; A O Anderson; J J Oppenheim; K Matsushima
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

6.  Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin.

Authors:  M Sticherling; E Bornscheuer; J M Schröder; E Christophers
Journal:  J Invest Dermatol       Date:  1991-01       Impact factor: 8.551

7.  Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis.

Authors:  B J Nickoloff; G D Karabin; J N Barker; C E Griffiths; V Sarma; R S Mitra; J T Elder; S L Kunkel; V M Dixit
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis.

Authors:  M Seitz; B Dewald; N Gerber; M Baggiolini
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

Authors:  C G Larsen; A O Anderson; E Appella; J J Oppenheim; K Matsushima
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

10.  Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells.

Authors:  J M Schröder; E Christophers
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

View more
  3 in total

1.  Interleukin-8 Levels in the Stratum Corneum as a Biomarker for Monitoring Therapeutic Effect in Atopic Dermatitis Patients.

Authors:  Susumu Murata; Sakae Kaneko; Eishin Morita
Journal:  Int Arch Allergy Immunol       Date:  2021-01-22       Impact factor: 2.749

2.  Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density.

Authors:  H D Foss; H Herbst; S Gottstein; G Demel; I Araujó; H Stein
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

3.  Beneficial effects of ROCEN (Topical Nano-arthrocen) on atopic dermatitis in mice.

Authors:  Ramin Goudarzi; Maryam Eskandarynasab; Ahad Muhammadnejad; Ahmad Reza Dehpour; Alireza Partoazar
Journal:  BMC Complement Med Ther       Date:  2021-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.